Location History:
- Ft. Lee, NJ (US) (2017)
- Fort Lee, NJ (US) (2014 - 2023)
Company Filing History:
1 out of 894 
1 out of 1,455 
6 out of 832,843 Years Active: 2014-2023
Title: The Innovative Contributions of Rui Rong Yuan
Introduction
Rui Rong Yuan is a notable inventor based in Fort Lee, NJ, who has made significant contributions to the field of medical science. With a total of seven patents to his name, Yuan's work primarily focuses on methods for treating inflammatory disorders and traumatic brain injuries. His innovative approaches have the potential to greatly impact patient care and treatment outcomes.
Latest Patents
Yuan's latest patents include groundbreaking methods for treating inflammatory brain diseases and traumatic brain injuries using stabilized non-hematopoietic erythropoietin (EPO) short peptides. This invention provides effective methods for addressing inflammatory components in patients suffering from these conditions. Another significant patent involves EPO-derived short peptides and their mimics, which serve as immuno/inflammatory modulators. This patent outlines the use of isolated stabilized EPO-derived peptides to protect against tissue damage in subjects with various forms of organ system injuries, along with methods for treating symptoms of diseases with inflammatory or autoimmune components.
Career Highlights
Throughout his career, Yuan has worked with various organizations, including the United States Government as represented by the Department of Veterans Affairs. His experience in these roles has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Yuan has collaborated with notable professionals in his field, including Peter C. Dowling and Wei Lu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Rui Rong Yuan's contributions to medical science through his innovative patents demonstrate his commitment to improving treatment options for patients with inflammatory disorders and traumatic brain injuries. His work continues to pave the way for future advancements in the field.